Literature DB >> 7465472

Serum theophylline concentrations during multiple dosing with two sustained release methylxanthine preparations in normal subjects.

J G Prior, D Berry, G M Cochrane.   

Abstract

In normal subjects, receiving multiple dosing regimens with Slophyllin and Phyllocontin in does calculated to give either 4 mg/kg or 6mg/kg theophylline free acid twice daily, serum theophylline concentrations were frequently less than 8 mg/l. Accumulation of the serum theophylline trough concentration occurred during the first 3 days of multiple dosing, and was followed by subsequent stabilization or even decline in serum theophylline trough concentrations. Side effects were noted with both Slophyllin and Phyllocontin, but only on the higher dosage regimens; they occurred within 24--48 hr of starting the drug, and tended to diminish if dosing was continued. The accumulation effect of serum theophylline concentrations may explain the timing of adverse effects, and should be avoided by starting methylxanthine therapy at a low dose. This may be increased after a few days. Further dosage adjustment may be necessary in some patients and should be facilitated by measurement of serum theophylline trough concentrations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7465472      PMCID: PMC2425933          DOI: 10.1136/pgmj.56.659.638

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  9 in total

1.  A comparison of slow-release salbutamol with slow-release aminophylline in nocturnal asthma.

Authors:  J S Milledge; J Morris
Journal:  J Int Med Res       Date:  1979       Impact factor: 1.671

2.  Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity.

Authors:  M H Jacobs; R M Senior; G Kessler
Journal:  JAMA       Date:  1976-05-03       Impact factor: 56.272

3.  Evaluation of oral bronchodilator therapy in asthmatic children. Bronchodilators in asthmatic children.

Authors:  M M Weinberger; E A Bronsky
Journal:  J Pediatr       Date:  1974-03       Impact factor: 4.406

4.  Rational intravenous doses of theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

5.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

6.  The relation of product formulation to absorption of oral theophylline.

Authors:  M Weinberger; L Hendeles; L Bighley
Journal:  N Engl J Med       Date:  1978-10-19       Impact factor: 91.245

7.  Serum theophylline concentrations in asthmatic children.

Authors:  A Sheen; R M Sly
Journal:  Ann Allergy       Date:  1978-12

8.  Plasma theophylline level and ventilatory function in chronic obstructive pulmonary disease during prolonged oral treatment with choline theophyllinate.

Authors:  K B Bülow; H Larsson; T Leideman
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

9.  Theophylline bioavailability following chronic dosing of an elixir and two solid dosage forms.

Authors:  D D Shen; M Fixley; D L Azarnoff
Journal:  J Pharm Sci       Date:  1978-07       Impact factor: 3.534

  9 in total
  1 in total

1.  Slow release theophyllines and chronic bronchitis.

Authors:  G M Cochrane
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.